HRAS
Biomarkers
HRAS is involved in the following curated
biomarkers.
Name |
Biomarker type |
Propositions |
Statements |
Wild type HRAS |
Wild type |
5 |
5 |
Therapeutic response
Precision oncology relationships for therapeutic response involving this gene.
Type |
Biomarker(s) |
Cancer type |
Therapy(ies) |
|
Sensitivity (+) |
Wild type HRAS,
Wild type KRAS
|
Colorectal Adenocarcinoma |
Fluorouracil,
Oxaliplatin,
Panitumumab
|
|
Sensitivity (+) |
Wild type HRAS,
Wild type KRAS
|
Colorectal Adenocarcinoma |
Panitumumab
|
|
Sensitivity (+) |
EGFR positive,
Wild type HRAS,
Wild type KRAS,
Wild type NRAS
|
Colorectal Adenocarcinoma |
Cetuximab
|
|
Sensitivity (+) |
EGFR positive,
Wild type HRAS,
Wild type KRAS,
Wild type NRAS
|
Colorectal Adenocarcinoma |
Cetuximab,
Irinotecan
|
|
Sensitivity (+) |
EGFR positive,
Wild type HRAS,
Wild type KRAS,
Wild type NRAS
|
Colorectal Adenocarcinoma |
Cetuximab,
Fluorouracil,
Oxaliplatin
|
|